5月13日，默沙东(MRK)盘中上涨5.03%，截至00:06，报79.795美元/股，成交8.19亿美元，总市值2003.68亿美元。
财务数据显示，截至2025年03月31日，默沙东收入总额155.29亿美元，同比减少1.56%；归母净利润50.79亿美元，同比增长6.66%。
资料显示，默克公司是一家领先的全球生物制药公司,它一直致力于为世界上许多最具挑战性的疾病提供药物和疫苗。如今,默克继续处于生物制药研究的最前沿,以推动预防和治疗威胁世界各地人民的疾病——包括癌症,心脏疾病,新出现的动物疾病,阿尔茨海默和包括艾滋和埃博拉在内的传染病。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.